Sarah Clevenger, MD
Physical Medicine & Rehabilitation · Lake Charles, LANPI 1427475482
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $348 of the $476 with a category attached, or 73.2%. 5 manufacturers reported payments, led by Kerecis Limited at 54.9% of the total.
Across 7 payments — averaging $67.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$261
- Pacira Pharmaceuticals Incorporated$143
- AbbVie$28
- Urgo Medical North America, LLC$23
- Mimedx Group, Inc.$20
What the payments were for
- Travel & lodging$12827%
- Food & beverage$34873%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 2 | $261 |
| Pacira Pharmaceuticals Incorporated | 2 | $143 |
| AbbVie | 1 | $28 |
| Urgo Medical North America, LLC | 1 | $23 |
| Mimedx Group, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$476 in reported general payments places this provider in the 60th percentile of 117 physical medicine & rehabilitation providers in Louisiana.
See all physical medicine & rehabilitation providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $9,451 |
| Gabapentin | 43 | $399 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $258 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $211 |
| Atorvastatin Calcium | 26 | $114 |
| Hydralazine Hcl | 12 | $112 |
| Pantoprazole Sodium | 21 | $106 |
| Losartan Potassium | 24 | $104 |
| Tamsulosin Hcl | 16 | $96 |
| Amlodipine Besylate | 33 | $91 |
| ClopidogrelClopidogrel Bisulfate | 20 | $75 |
| Famotidine | 13 | $64 |
| Metoprolol Tartrate | 21 | $52 |
| Tramadol Hcl | 26 | $40 |
| Meloxicam | 13 | $28 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Lake Charles
- William RogenmoserAlexandria$350K
- Andrea ToomerMarrero$170K
- Taylor ColonCovington$26K
- Erik DavisMetairie$12K
- Stephen RynickMarrero$12K
- Fred DefranceschMetairie$11K
- Eric FinckeNew Orleans$9K
- Casey MurphyNew Orleans$8K
- Joshua KaufmanNew Orleans$8K
- Navneet SharmaRuston$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.